Cancer Research and Treatment

Original Article

In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer: Hye Youn Kwon, Im-kyung Kim, Jeonghyun Kang, Seung-Kook Sohn, Kang Young Lee; Cancer Res Treat. 2016;48(3):970-977. Published online October 22, 2015; DOI: https://doi.org/10.4143/crt.2015.140

Purpose
We evaluated the usefulness of the in vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) for prediction of clinical response to fluorouracil-based adjuvant chemotherapy in stage II colorectal cancer. Materials and Methods Tumor specimens of 86 patients with pathologically confirmed stage II colorectal adenocarcinoma were tested for chemosensitivity to fluorouracil. Chemosensitivity was determined by cell death rate (CDR) of drug-exposed cells, calculated by comparing the intracellular ATP level with that of untreated controls. Results Among the 86 enrolled patients who underwent radical surgery followed by fluorouracilbased adjuvant chemotherapy, recurrence was found in 11 patients (12.7%). The CDR ≥ 20% group was associated with better disease-free survival than the CDR < 20% group (89.4% vs. 70.1%, p=0.027). Multivariate analysis showed that CDR < 20% and T4 stage were poor prognostic factors for disease-free survival after fluorouracil-based adjuvant chemotherapy. Conclusion In stage II colorectal cancer, the in vitro ATP-CRA may be useful in identifying patients likely to benefit from fluorouracil-based adjuvant chemotherapy.

Citations

Citations to this article as recorded by

Clinical Utility of Patient-Derived Cell-Based In Vitro Drug Sensitivity Testing for Optimizing Adjuvant Therapy in Dogs with Solid Tumors: A Retrospective Study (2019–2023)
Young-Rok Kim, Kieun Bae, Ja-Young Lee, Soon-Wuk Jeong, Hun-Young Yoon, Hyun-Jung Han, Jae-Eun Hyun, Aryung Nam, Ji-Hwan Park, Kyong-Ah Yoon, Jung-Hyun Kim
Animals.2025; 15(8): 1146. CrossRef
Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer
Elsa Garza‑Treviño, Herminia Martínez‑Rodríguez, Paulina Delgado‑González, Orlando Solís‑Coronado, Rocio Ortíz‑Lopez, Adolfo Soto‑Domínguez, Víctor Treviño, Gerardo Padilla‑Rivas, Jose Islas‑Cisneros, Adriana Quiroz‑Reyes, Salvador Said‑fernández
Molecular Medicine Reports.2021;[Epub] CrossRef
Sample preparation strategies for high‐throughput mass spectrometry imaging of primary tumor organoids
Jillian Johnson, Joe T. Sharick, Melissa C. Skala, Lingjun Li
Journal of Mass Spectrometry.2020;[Epub] CrossRef
METHODOLOGICAL APPROACHES TO THE DETERMINATION OF CHEMORESISTANCE OF HUMAN CANCER CELLS TO ANTI-CANCER DRUGS
K. I. Kirsanov, K. A. Kuzin, T. I. Fetisov, E. A. Lesovaya, G. A. Belitskiy, M. G. Yakubovskaya
Siberian journal of oncology.2020; 19(3): 122. CrossRef
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer
Lan Ying Li, Sang Wun Kim, Eun Ji Nam, JungYun Lee, Sunghoon Kim, Young Tae Kim
International Journal of Gynecological Cancer.2019; 29(2): 334. CrossRef
Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells
Shanwen Chen, Taohua Yue, Zhihao Huang, Jing Zhu, Dingfang Bu, Xin Wang, Yisheng Pan, Yucun Liu, Pengyuan Wang
Cancer Letters.2019; 466: 49. CrossRef
The methods of in vitro selection of chemotherapeutic druds for individual chemotherapy of maligant tumors in patinets
A. N. Chernov, E. P. Barantsevich, V. N. Kalunov, M. M. Galagudza
Translational Medicine.2018; 5(3): 45. CrossRef
Cell cultures of human malignant tumors in development of new anticancer therapies
А.Н. Чернов, Е.П. Баранцевич, Э.С. Галимова, М.М. Галагудза
Nauchno-prakticheskii zhurnal «Patogenez».2018; (4()): 13. CrossRef

13,751 View
84 Download
5 Web of Science
8 Crossref

First
Prev
Page of 1
Next
Last

Search